TRENT HICKS: Open Payments
NPI 1598420911 · FAYETTEVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,502 in 68 payments from 18 companies in 2025. Trend: 2023 $1,219 · 2024 $1,110 · 2025 $1,502
Food & beverage: $1,502
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $377 |
| Collegium Pharmaceutical, Inc. | 6 | $187 |
| AstraZeneca Pharmaceuticals LP | 8 | $176 |
| GlaxoSmithKline, LLC. | 11 | $172 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $159 |
| Axsome Therapeutics, Inc. | 3 | $72 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 3 | $58 |
| Lundbeck LLC | 3 | $54 |
| Dexcom, Inc. | 2 | $46 |
| Corium, LLC | 3 | $35 |
Products named: QULIPTA, Jornay PM, TRELEGY ELLIPTA, CAPLYTA, BREZTRI, JARDIANCE, REXULTI, Dexcom G6 Transmitter.
Industry payments across AR — which companies pay providers there.
